当前位置: X-MOL 学术Clin. Transl. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Disease extent and anti‐tubercular treatment response correlates with Mycobacterium tuberculosis‐specific CD4 T‐cell phenotype regardless of HIV‐1 status
Clinical & Translational Immunology ( IF 5.8 ) Pub Date : 2020-09-28 , DOI: 10.1002/cti2.1176
Catherine Riou 1, 2 , Elsa Du Bruyn 1 , Sheena Ruzive 1 , Rene T Goliath 1 , Cecilia S Lindestam Arlehamn 3 , Alessandro Sette 3, 4 , Alan Sher 5 , Daniel L Barber 6 , Robert J Wilkinson 1, 7, 8, 9
Affiliation  

The development of non‐sputum‐based assays for tuberculosis (TB) diagnosis and treatment monitoring is a key priority. Recent data indicate that whole blood‐based assays to assess the phenotype of Mycobacterium tuberculosis (Mtb)‐specific CD4 T cells hold promise for this purpose and require further investigation in well‐characterised TB cohorts. In this study, we investigated the relationship between the phenotypic signature of Mtb‐specific CD4 responses, TB disease extent and treatment response.

中文翻译:

无论 HIV-1 状态如何,疾病程度和抗结核治疗反应都与结核分枝杆菌特异性 CD4 T 细胞表型相关

开发用于结核病 (TB) 诊断和治疗监测的非痰检测方法是一项关键优先事项。最近的数据表明,用于评估结核分枝杆菌(Mtb) 特异性 CD4 T 细胞表型的基于全血的分析有望实现这一目的,并且需要对特征明确的 TB 队列进行进一步研究。在本研究中,我们调查了 Mtb 特异性 CD4 反应的表型特征、结核病疾病程度和治疗反应之间的关系。
更新日期:2020-09-28
down
wechat
bug